Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The dexamethasone suppression test in depression.

H S Green, J M Kane

    Clinical Neuropharmacology
    |March 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    The dexamethasone suppression test (DST) shows abnormalities in some major depressive disorder patients, especially those with melancholic depression. This test may help identify subgroups but doesn't predict treatment response.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Society, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, London, Ont. Sept. 15-18, 2011.

    Canadian journal of surgery. Journal canadien de chirurgie·2022
    Same author

    How and when to use clozapine.

    Acta psychiatrica Scandinavica·2019
    Same author

    Detecting relapse in youth with psychotic disorders utilizing patient-generated and patient-contributed digital data from Facebook.

    NPJ schizophrenia·2019
    Same author

    Clozapine as an early-stage treatment.

    Acta psychiatrica Scandinavica·2018
    Same author

    Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia.

    Acta psychiatrica Scandinavica·2018
    Same author

    Abnormalities of gait caused by ankle arthritis are improved by ankle arthrodesis.

    The bone & joint journal·2016
    Same journal

    Characterization of Propranolol Use and Outcomes in Traumatic Brain Injury at a Level I Trauma Center.

    Clinical neuropharmacology·2026
    Same journal

    Review of Medications That Reduce Neurological Deficits in Patients With Traumatic Brain Injury.

    Clinical neuropharmacology·2026
    Same journal

    Pre-Existing Peak-Dose Dyskinesia and Light Body Weight as Predictors of Ropinirole Patch Dose Modification in Parkinson Disease: A Multicenter Retrospective Study.

    Clinical neuropharmacology·2026
    Same journal

    A Double-blind, Placebo-controlled Study of Lumateperone in the Treatment of Borderline Personality Disorder.

    Clinical neuropharmacology·2026
    Same journal

    Yesterday Once More: Revisiting Catatonia in an Elderly Stroke Patient.

    Clinical neuropharmacology·2026
    Same journal

    Overlapping Hyperosmolar Therapy in Patients With Elevated and Refractory Intracranial Pressure.

    Clinical neuropharmacology·2026
    See all related articles

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Clinical Psychology

    Background:

    • Major depressive disorder (MDD) diagnosis and subtyping remain challenging.
    • The dexamethasone suppression test (DST) has been investigated as a potential biological marker for depression.
    • Understanding biological correlates of depression subtypes is crucial for targeted interventions.

    Purpose of the Study:

    • To evaluate the utility of the DST in identifying subgroups of patients with major depressive disorder.
    • To assess the DST's ability to differentiate MDD patients from healthy controls and those without affective illness.
    • To determine if the DST can predict treatment response to somatic therapies.

    Main Methods:

    • The study analyzed data on the DST in patients diagnosed with major depressive disorder and in control groups.

    Related Experiment Videos

  • Patients were characterized based on clinical presentation, including "endogenomorphic" or "melancholic" features.
  • Treatment response data to somatic therapies were correlated with DST results.

    • Main Results:

    • The DST was found to be abnormal in a significant subgroup of MDD patients, particularly those with melancholic features.
    • DST abnormalities were less common in normal controls and patients without affective illness.
    • The DST did not demonstrate value in predicting treatment response to somatic therapies.

    Conclusions:

    • The DST shows promise in delineating specific subgroups within major depressive disorder for further research.
    • Clinical presentation and patient history remain paramount for guiding somatic treatment decisions.
    • Further research on diagnostic criteria and DST methodology could enhance understanding of affective illness variants and depression pathophysiology.